Corrosion Mechanisms in Orthopaedic Implants

Corrosion is the electrochemical degradation of a metal in its environment. An orthopaedic implant sits in an aqueous solution of chloride ions (0.9% NaCl) at pH 7.4 and 37°C, surrounded by proteins and other organic molecules, and that combination is aggressive to metal.

The alloys themselves are covered separately — titanium alloys, cobalt-chrome alloys, stainless steel and ceramics — and corrosion should be read alongside wear mechanisms, because the two act together at a taper and are separated only for teaching. The clinical consequences have their own pages: trunnionosis and taper corrosion, metal-on-metal complications and wear-related osteolysis.

Why the body is hostile. Chloride ions, the aggressive anion, attack passivation layers; proteins and amino acids affect the electrochemical reactions; cyclic mechanical loading creates stress and micro-motion; and oxygen gradients develop in crevices and gaps. Each of these reappears below as the driver of a particular type of corrosion.

Why it matters. Metal ion release has four consequences:

1. Implant mechanical failure - material loss weakens the structure
2. Metal hypersensitivity - Type IV delayed hypersensitivity (ALVAL)
3. Local tissue toxicity - soft tissue necrosis and pseudotumour
4. Systemic metal elevation - unclear long-term effects

The reaction. Corrosion is an oxidation-reduction reaction. At the anode the metal loses electrons and goes into solution as ions (M → M^n+ + ne^-); that is the corrosion reaction, and metal ion release is what it produces. The electrons flow to the cathode, where oxygen is reduced to hydroxyl ions (O2 + 2H2O + 4e^- → 4OH^-), which completes the circuit.

Passivation. Every orthopaedic metal owes its corrosion resistance to a thin oxide film that keeps the metal out of contact with the electrolyte. Titanium forms TiO2, typically 2-10 nm thick; stainless steel and cobalt-chromium form Cr2O3, which on CoCr is 1-3 nm thick. The film is amorphous, has semiconductor properties, dissolves in an acidic environment and is disrupted by mechanical abrasion. Corrosion occurs when passivation is disrupted, and every section of this topic returns to that one idea.

Why titanium resists corrosion. Titanium is a reactive metal thermodynamically, yet its TiO2 film is tenacious, extremely stable and self-healing: scratched, it reforms in milliseconds in the presence of oxygen. Cobalt-chromium relies on a Cr2O3 film that is less robust.

The polarisation curve. Whether the passive film holds is decided by the anodic polarisation curve, which plots corrosion current against electrode potential:

• Active region - at low potential the bare metal dissolves freely (high current)
• Passive region - as potential rises a protective oxide film forms and the current drops to a very low, near-constant value; the metal is protected across a wide "passive window"
• Breakdown (pitting) potential - above a critical potential the passive film breaks down locally and the current rises sharply again; this is where pitting and crevice corrosion initiate
• Transpassive region - at very high potential the oxide itself dissolves and general corrosion resumes

The wider the passive window and the higher the breakdown potential, the more corrosion-resistant the alloy. Titanium has a very high, self-healing breakdown potential; stainless steel has the lowest, which makes it the most pitting-prone of the implant alloys.

Two modifiers the body imposes. Chloride ions lower the breakdown potential: they adsorb at film defects and prevent re-passivation, so the safe passive window narrows in physiological saline. And when dissimilar metals are coupled, a large cathode driving a small anode, the galvanic area effect, concentrates the entire galvanic current onto a tiny area, so a small de-passivated patch within a taper crevice corrodes very rapidly. A small anode with a large cathode is the worst-case geometry, and between them these two modifiers explain why localised breakdown happens in crevices and at mixed-metal couples.

View larger

Galvanic Corrosion

Mechanism. Two dissimilar metals in electrical contact in an electrolyte form a cell, and the less noble (more anodic) metal corrodes preferentially. The farther apart the two metals sit in the galvanic series, the larger the potential difference and the faster the anodic metal corrodes.

The galvanic series in physiological saline, most noble to least noble:

1. Platinum (most noble, corrodes least)
2. Cobalt-chromium alloys
3. Titanium alloys
4. Stainless steel 316L
5. Magnesium (least noble, corrodes most)

The clinical case: a cobalt-chromium head on a titanium stem. CoCr is more noble than titanium in the physiological environment, so at the taper the titanium is the anode and the CoCr head the cathode. Titanium oxidises (Ti → Ti^4+ + 4e^-), micro-motion disrupts its passivation layer, and the galvanic current accelerates the attack; the product is black debris of titanium oxide and chromium oxide at the taper. Retrieval studies show worse corrosion at CoCr/Ti tapers than at CoCr/CoCr tapers, which is why a matched couple is preferred, why the taper is assembled clean, dry and with a single impaction, and why adequate taper engagement to minimise micro-motion matters.

Crevice Corrosion

Definition. Localised corrosion within a shielded area, a crevice or gap, where oxygen is depleted. The crevice starts passive and then turns on itself in a sequence worth being able to recite.

Where. Modular taper junctions (head-neck and neck-stem), screw-plate and plate-bone interfaces, modular knee tibial tray interfaces, and under a bone cement mantle.

MACC. Superimpose micro-motion on a crevice and the result is mechanically-assisted crevice corrosion. The motion continuously disrupts the passivation layer, fresh metal is exposed to the aggressive crevice environment, mechanical wear debris is added to the corrosion products, and the effect is synergistic: the corrosion rate is much higher than either process alone. MACC is the primary mechanism of modular taper corrosion in hip implants and the leading cause of modular hip taper failures.

What separates MACC from simple fretting corrosion is the crevice. Fretting can happen between any two surfaces; MACC occurs specifically in crevice geometry, where the acidic, chloride-rich, oxygen-depleted environment accelerates passive-layer breakdown once micro-motion is added.

Pitting Corrosion

Definition. A highly localised breakdown of passivation that creates small pits propagating deep into the metal: a small surface opening with deep penetration.

Mechanism. The passivation layer has a microscopic defect, an inclusion or a scratch. Chloride ions adsorb there (Cl^- is a small anion that penetrates the oxide layer and prevents re-passivation), the local breakdown creates a micro-anode, and the pit propagates inward, autocatalytic in the same way as a crevice. The pit can then act as a stress concentration site for fatigue crack initiation.

Clinical relevance. Pitting is less common than fretting and crevice corrosion in orthopaedics, occurs on stainless steel more than on titanium or CoCr, and starts at surface contamination sites. Rough surfaces are more susceptible than polished ones, so surface finishing reduces susceptibility.

Fretting Corrosion

Definition. Combined mechanical wear and corrosion from small-amplitude oscillatory motion between two surfaces, typically less than 100 microns.

Mechanism. The micro-motion abrades the passivation layer away; the fresh metal exposed oxidises rapidly and forms debris; the debris is trapped between the surfaces as third-body wear; and the cycle repeats with each loading cycle, so the degradation is synergistic mechanical and chemical. The characteristic product is black debris of metal oxide particles, which distinguishes fretting from pure wear.

Where. Fretting corrosion is the dominant wear mode at modular tapers. It also occurs between the polyethylene backside and the tibial tray, at screw-plate interfaces where there is micro-motion, and where cerclage wires rub against bone or plate.

View larger

Environmentally-Assisted Cracking: Stress Corrosion Cracking and Corrosion Fatigue

The four types above describe metal loss. A further category describes cracking that occurs when mechanical stress and the corrosive environment act together, and it causes sudden, often brittle, implant fracture rather than gradual material loss.

Stress corrosion cracking needs three things together: a susceptible alloy, a specific corrosive environment (chloride) and a sustained tensile stress. The crack tip is both mechanically and chemically driven, so failure can occur well below the normal yield strength.

Corrosion fatigue is the synergy of cyclic loading and corrosion. In a corrosive medium a metal loses its true fatigue (endurance) limit, so the S-N curve keeps falling and the implant can fail at a stress that would be safe in air. A corrosion pit or a fretting scar is the stress raiser that initiates the fatigue crack, which is the mechanistic link between localised corrosion and the rare but catastrophic complication of stem, plate or modular-neck fracture. The pure mechanical S-N behaviour and fatigue limit are developed in the fatigue-failure topic.

Release. When corrosion occurs, metal ions are released into the surrounding tissues and the systemic circulation.

Distribution. Ions and particles travel outward in a predictable order:

1. Local tissues - highest concentration, direct toxicity
2. Regional lymph nodes - metal particles transported by macrophages
3. Systemic circulation - ions absorbed into the bloodstream
4. Distant organs - accumulation in liver, spleen and kidney

Local effects. Metal produces four things locally. Metallosis is macroscopic black or grey staining of the tissues. ALVAL is the lymphocyte-dominated reaction described below. A pseudotumour is a soft tissue mass with necrosis, not a true neoplasm. Osteolysis is particle-induced bone resorption. Macrophages engulf the metal particles, ions bind to proteins, the debris accumulates in the pseudocapsule and can extend to bone.

View larger

ALVAL. The aseptic lymphocyte-dominated vasculitis-associated lesion is conventionally described as a Type IV delayed hypersensitivity reaction to metal ions, and the sequence below is the mechanism to be able to draw. State it as the leading hypothesis rather than settled fact, because the studies cited in the evidence section do not agree that it is proven, and an examiner who knows the literature will reward the candidate who says so.

For hypersensitivity. Willert's landmark histology found only few metal particles in tissues showing a florid lymphocytic reaction, which argues the response is immune rather than simply proportional to particle volume; and patients re-revised to another MoM articulation had no symptom relief (PMID 15637030).

Against, or at least unresolved. In Langton's ARMD series the lymphocyte transformation tests were negative, leaving the hypersensitivity contribution uncertain, while ARMD patients had significantly higher cobalt and chromium levels and greater bearing wear, a picture more consistent with a dose-dependent toxic reaction (PMID 20044676). Pandit's pseudotumour series concluded the aetiology was probably multifactorial, toxic versus hypersensitivity (PMID 18591590).

The honest synthesis, and a good viva answer. There are almost certainly two overlapping processes: a dose-dependent cytotoxic response to a high particle and ion burden, and a genuine cell-mediated hypersensitivity that can occur at low particle loads in susceptible individuals. That accounts for the clinical paradox that some patients fail catastrophically with modest wear while others tolerate very high ion levels without a reaction, and it explains why serum ions are a useful screening biomarker but a poor predictor in the individual.

The classical hypersensitivity sequence.

Histology. A dense perivascular lymphocytic infiltrate, T-cell predominant, with a diffuse lymphocytic infiltrate, aseptic fibrinoid necrosis, vascular endothelial damage, necrotic tissue containing metal debris, and no infection. Grossly the tissues are stained grey-black, there may be a pseudotumour, and any effusion is sterile.

View larger

View larger

Presentation. Pain is the most common symptom. The others are a soft tissue mass (a pseudotumour on imaging), instability or dislocation from soft tissue destruction, and elevated serum cobalt and chromium.

Systemic effects. The long-term consequences are unclear. Cobalt can cause cardiomyopathy and hypothyroidism at very high levels, and its systemic toxicity is neurological and cardiac; chromium carries a theoretical carcinogenic risk in the Cr^6+ form and accumulates in the kidney; nickel is a known allergen and hypersensitivity to it is common. Most patients with moderate elevation (5-10 ppb) have no systemic symptoms, but the long-term data are limited.

The head-neck taper. The most critical corrosion site in modern THA is the Morse taper between femoral head and stem: a contact area of 50-150 mm² depending on design, a taper angle typically 5°40', and a crevice geometry that is the ideal environment for MACC once micro-motion disrupts the protective oxide layer. Surface roughness affects seating and corrosion, and the material couple (CoCr/Ti) is a critical factor.

Modular necks. A modular neck system adds a second taper at the stem-sleeve junction, for neck angle and offset adjustability, and with it a second corrosion site. Double modular systems produce more corrosion debris and a greater surface area for metal ion release, and their higher failure rates led to some recalls.

Taper design. The design variables that decide how much a taper frets, and why certain implant designs and materials fail preferentially:

Beyond the four mechanisms above, with MACC as the combination that matters clinically, corrosion is classified by the severity of what is found, by the pattern of damage on a retrieved taper, and by which of wear and corrosion drives the other.

Severity. The grade ties the appearance of the taper to the serum ions and to the action taken.

Goldberg classification of taper corrosion. Four patterns, in order of material loss:

• Type I - Fretting: a burnished appearance with material transfer between the surfaces and no significant material loss; early-stage corrosion
• Type II - Crevice: black debris deposition, localised pitting and pH-driven dissolution, with moderate material loss
• Type III - Mixed: combined fretting and crevice, which is true MACC; the most common severe pattern, with significant material loss
• Type IV - Etching: generalised surface attack by electrochemical dissolution, with severe material loss and often fatigue failure

Tribocorrosion. The same wear-corrosion synergy is classified by which process drives the other.

Serum cobalt and chromium. The primary biomarker for MoM monitoring. Under 1 ppb (μg/L) is normal; 2-7 ppb is elevated and calls for increased surveillance; over 7 ppb is concerning and prompts further investigation; over 20 ppb is critical and revision is often indicated. The result is only as good as the sample: a fasting morning sample, because some foods contain metals, drawn into a metal-free trace element tube, avoiding contamination from the needle hub, and run by a laboratory with a validated ICP-MS assay. Recent activity may elevate levels.

When. Annually as a minimum for every MoM hip, at presentation when symptomatic, and at 3 and 12 months after revision.

Imaging. Serum ions and MARS MRI are the cornerstone investigations for suspected corrosion-related pathology; radiographs come first and are the baseline everything else is compared with.

MARS MRI (Metal Artefact Reduction Sequence) uses specialised pulse sequences and post-processing to reduce metal artefact, so that the periprosthetic soft tissues can be seen and ALVAL, pseudotumour and fluid collections detected.

View larger

View larger

Lymphocyte transformation testing measures T-cell reactivity to metal ions on cobalt, chromium and nickel panels, and a positive result suggests Type IV hypersensitivity. Its use for pre-operative implant selection is controversial, it has a place in persistent symptoms after revision, and it remains a research tool rather than routine practice.

Synovial fluid. Aspirate a turbid grey-black fluid and it is corrosion debris; the metal ion concentration in the fluid is very high. Send it for culture and cell count to rule out infection, and for cytology, where macrophages containing metal particles and a lymphocyte predominance in ALVAL help to differentiate the reaction from infection.

Elevated metal ions point towards ARMD, but infection must always be excluded by aspiration, because the two can coexist and their management differs fundamentally.

Anderson classification of ALVAL on MRI. The MRI appearance of the lesion carries prognostic weight.

Intraoperative assessment. The retrieved taper is scored visually for corrosion, black debris being the corrosion product, its material loss measured by weight or volume, and photographed for documentation. Tissue goes for histopathology, which grades the ALVAL lymphocyte score, the extent of necrosis and the quantity of metal debris, and for culture and frozen section to rule out infection.

Algorithm

View larger

Asymptomatic, ions under 2 ppb and stable. Low-risk surveillance: annual clinical review and metal ion levels, radiographs every 2 years, and patient education on the symptoms to report. Continue indefinitely. Nothing more is needed unless symptoms develop, ions rise progressively or imaging abnormalities appear.

Asymptomatic, ions 2-7 ppb or rising, or an imaging abnormality. Intermediate risk: 6-monthly clinical review and metal ion levels, and MARS MRI to assess the soft tissues, annually. Revision is discussed if the ions rise progressively, imaging shows a pseudotumour, or the patient is high-demand with a long life expectancy.

Symptomatic with ions over 7 ppb, or progressive. High risk: plan revision, with specialist referral and pre-operative optimisation, once infection and the other mimics have been excluded.

Non-operative measures. Activity modification, fewer loading cycles and lower-impact activities, may reduce metal ion generation, but the evidence is limited, it does not address the underlying pathology, and it may only delay an inevitable revision. Medical optimisation before revision means cardiac assessment if cobalt is high, neurological assessment if symptomatic, attention to nutritional status and comorbidity management; the cobalt toxicity concerns are cardiomyopathy, thyroid dysfunction, visual and hearing impairment and neurological symptoms.

Deciding. The decision weighs symptoms, the metal ion level and its trend, imaging (pseudotumour, ALVAL), bone stock, patient age and activity, surgical risk and the alternative implant options, through a multidisciplinary approach with shared decision-making. Individualised management balances the risks of revision against the consequences of continued corrosion.

Head exchange, when the stem is well fixed. Indicated for taper corrosion with a well-fixed stem, good bone stock and no extensive tissue destruction. Dislocate the hip and remove the head, clean the taper thoroughly and dry it, inspect it for damage, and seat a new ceramic head on the clean, dry taper with a single firm impaction. If the taper is damaged, use a sleeve adapter.

Complete revision. For a loose stem, severe taper damage or fracture, extensive osteolysis, or a pseudotumour with bone destruction. It needs an extended approach for exposure, thorough debridement of necrotic tissue, revision of the acetabulum if affected, a new stem with modular options, and bone grafting where needed.

Approach. Large pseudotumours often extend posteriorly and need to be seen in full for complete excision, so a posterior approach is often the best access. The options are an extended posterior approach, a trochanteric osteotomy if needed, and combined approaches for large pseudotumours.

Tissue handling. Document the tissue appearance with photographs, send tissue for histology (ALVAL score) and for culture to rule out infection, assess abductor integrity and viability, and assess and classify the bone defects.

The taper. What is done to it depends on what is found.

Bearing at revision. Ceramic-on-ceramic eliminates metal ions; ceramic-on-polyethylene (XLPE) has very low wear; metal-on-polyethylene is acceptable if a ceramic taper is used. Avoid another metal-on-metal bearing, a mixed metal taper couple, and large metal heads on modular tapers.

Stability. After ALVAL or a pseudotumour the abductors are often compromised and the dislocation risk is higher, so consider a dual mobility cup, larger head sizes within reason, and a constrained liner if severe; soft tissue repair, tendon transfers for abductor deficiency and an extended rehabilitation protocol may be needed. Revision for corrosion has higher complication rates than routine revision because of the tissue destruction, with dislocation rates of 10-20% in severe ALVAL cases with abductor damage, and the bearing choice and soft tissue management are how that is planned for.

View larger

Local tissue destruction. ALVAL and pseudotumour produce soft tissue necrosis around the implant, a solid or cystic pseudotumour, abductor muscle destruction and, rarely, femoral nerve compression. Bone is involved through debris-driven osteolysis and periprosthetic bone loss, which may compromise fixation at revision.

View larger

Systemic cobalt toxicity. Cardiomyopathy, thyroid dysfunction, peripheral neuropathy, and visual and hearing impairment, typically with very high levels, usually over 50-100 ppb. It may be reversible with revision, and cardiac monitoring is recommended.

Complications of the revision itself. Intraoperatively the tissue quality is poor for repair, bone has been lost to osteolysis, exposure is difficult through scarring and inflamed tissue bleeds; the specific risks are nerve injury (femoral, sciatic), fracture of weakened bone and incomplete debridement. The early postoperative complications are dislocation, wound complications, deep vein thrombosis and infection, driven by poor tissue healing capacity, the effect of metallosis on wound healing and abductor deficiency.

Cobalt cardiomyopathy. Rare but serious. It presents with dyspnoea, fatigue and oedema, a dilated cardiomyopathy on echocardiography, sometimes as acute heart failure, and the other toxic effects are often present. The diagnosis rests on a high serum cobalt (often over 100 ppb), ECG conduction abnormalities, and the exclusion of other causes of cardiomyopathy.

Treatment is urgent revision with cardiology involvement and standard heart failure management, monitoring the recovery of cardiac function. It is often reversible once the source is removed, improving over weeks to months, though some patients have residual damage.

Metal ions after revision. Sample at 3 months (the post-revision baseline), at 12 months (to assess the decline) and then annually until levels normalise. Expect a rapid initial decline over the first 3-6 months and gradual normalisation over 1-2 years; levels may not return to normal in every patient.

Clinical review. At 6 weeks (wound, weight-bearing), 3 months (function), 6 months (metal ions, radiographs), 12 months (comprehensive review) and then annually. At each visit assess hip function (Oxford Hip Score), stability (dislocation precautions) and symptoms (pain, clicking).

Systemic toxicity after revision. If there was cobalt toxicity before revision, obtain a baseline echocardiogram, arrange cardiology follow-up and monitor cardiac function serially: it usually improves after revision, recovery may take 6-12 months, and some patients have residual dysfunction. Document any peripheral neuropathy before revision; it may improve, some sensory loss may persist, and nerve conduction studies are used if severe. Monitor thyroid function, and vision and hearing if affected; most symptoms are reversible.

Long term. Survival of the revision implant is generally good with adequate debridement, may be compromised by bone loss, depends on the component choice, and ceramic bearings reduce the risk of re-corrosion. Pain and function improve but may not return to the pre-failure baseline; abductor weakness is often permanent and some patients have persistent limitations.

Metal ion decline. A mean 50-70% reduction at 12 months, with normalisation (under 2 ppb) in most patients; some have persistent elevation, and the rate of decline varies with the extent of the initial metallosis, the completeness of debridement and the bearing chosen.

Function. The Oxford Hip Score improves significantly, the Harris Hip Score by a mean of 20-30 points, and 70-85% of patients are satisfied. Scores often do not reach primary THA levels, abductor weakness limits function, and some persistent pain is common.

Re-revision. Rates at 5 years, by source and by scenario.

Dislocation. 5-10% with minimal abductor damage and 15-25% with significant abductor loss; constrained liners reduce it but do not eliminate it, and the risk is highest in the first 6 months. The risk factors are abductor muscle necrosis, a large tissue resection, previous dislocation and non-compliance with precautions.

Infection. 2-5%, higher than after primary THA, because the tissue is compromised and the surgery prolonged. Prevention is antibiotic prophylaxis, meticulous technique and avoiding excessive tissue handling.

Survivorship. At 1 year most patients have a significant improvement in pain and function, and the metal ions have declined. At 5 years implant survival is 85-90% in most series, function is stable, and some patients need re-revision for instability or other causes. At 10 years the data are limited; results appear comparable to other revision scenarios, and bone stock preserved at the initial revision matters. Outcomes depend heavily on the tissue and bone damage present before revision, which is the case for revising early.

Failed metal-on-metal hips. In most modern MoM failures the primary failure mode is taper corrosion, not bearing surface wear. Retrievals show severe MACC with debris at the taper while the bearing surfaces are often well preserved; mixed metal couples (CoCr/Ti) show worse corrosion, and a large head diameter increases the mechanical stress on the taper.

Risk factors. The taper corrodes faster with:

• A large femoral head diameter (greater than 36mm), which puts higher torque on the taper
• Increased offset, which raises the moment arm on the taper
• High patient BMI and activity level
• A mixed metal couple (CoCr on Ti)
• Poor taper assembly (contamination, multiple impacts)

Taper assembly. The steps that minimise MACC, and the reason for each:

• Clean and dry - contaminants prevent full seating and increase micro-motion
• Single impaction - multiple impacts damage the taper surface
• Adequate force - ensures taper engagement and minimises micro-motion
• Matched materials - CoCr on CoCr eliminates the galvanic component

View larger

Material selection. Titanium stems have excellent corrosion resistance but are the weaker partner at the taper when coupled with CoCr; CoCr stems have a stronger taper but are heavier and stiffer. Ceramic heads eliminate metal taper corrosion at the cost of the historical fracture concern, and a ceramic head on a titanium stem is the popular modern compromise.

What a ceramic head does not do. The retrieval panels below show the material-related difference between ceramic and cobalt-chromium heads, and they also show that a ceramic head does not make the taper interface immune to fretting or to metal transfer. Use the retrieval score as a descriptor of what was found, not as a validated bedside severity scale.

View larger

View larger

View larger